
Number of publications published per year by Stepanova, Maria. (Source : PubMed)

Distribution of publications types for Stepanova, Maria. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Vietnamese community screening for hepatitis B virus and hepatitis C virus.
J. Viral Hepat.
2010
Clinical predictors of fibrosis in patients with chronic liver disease.
Aliment. Pharmacol. Ther.
2010
Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C.
J. Viral Hepat.
2009
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
Clin. Gastroenterol. Hepatol.
2009;7;11
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Liver Int.
2009;29;9
Predictors of health-related quality of life in patients with chronic liver disease.
Aliment. Pharmacol. Ther.
2009;30;5
Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.
Hepatology
2009;49;3

Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study.
Rejuvenation Res
2008;11;4

Adipokines and cytokines in non-alcoholic fatty liver disease.
Aliment. Pharmacol. Ther.
2008;27;5
[ See timeline ] [ See all publications ]
means that Stepanova, Maria has 4 papers cited a least 4 times - methodology
Center for Liver Diseases at Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.